Join Now

Category Archives: BioUtah News

Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

By Denise Bell | Published October 9, 2020

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical device company that has developed the XenoscopeTM, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed to be fog proof, the Xenoscope minimizes common visualization challenges and provides consistent image quality through electrocautery smoke. MPVF’s […]

Also posted in Funding, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

By Denise Bell | Published October 9, 2020

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center. This new centralized office builds on the work by the Center for Technology & Venture Commercialization (TVC) and will facilitate the U’s efforts to drive technology commercialization and economic […]

Also posted in State News, Utah's Life Sciences Companies | | Leave a comment

Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

By Denise Bell | Published October 2, 2020

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized by Utah Business Magazine as among Utah’s top C-Suite executives. In introducing the 2020 CXO of the Year honorees, the magazine notes that “now more than ever we need strong leaders to guide our businesses forward and […]

Also posted in Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Foldax Named Finalist in the Fierce Innovation Awards

By Denise Bell | Published October 2, 2020

Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma. The company was selected as a finalist for its innovative TriaTM heart valve. The Tria valve reimagines the heart valve by incorporating a new, […]

Also posted in Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Alucent Biomedical Announces $35 Million Series B Financing

By Denise Bell | Published October 2, 2020

Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is treated, yesterday announced the close of a $35 million Series B financing round. The funding will support two clinical trials to evaluate Alucent’s novel treatment for peripheral artery disease (PAD) of the lower extremities. PAD is a […]

Also posted in Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration

By Denise Bell | Published September 25, 2020

IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung Test™ for lung cancer has been formally accepted for submission to China’s National Medical Products Administration (NMPA), formerly known as the Chinese Food and Drug Administration (CFDA).  Mr. Jared Bauer, IONIQ Sciences CEO, stated, “We are excited […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Announces New Data from Phase 1 Solid Tumor Study

By Denise Bell | Published September 25, 2020

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase 1 study evaluating dubermatinib (TP-0903) in patients with advanced solid tumors.  “These preliminary data presented at ESMO 2020 are encouraging as we learn more about how dubermatinib may inhibit the AXL kinase protein and sensitize cancer cells […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

RenalytixAI Receives California Commercial Lab Certification

By Denise Bell | Published September 25, 2020

RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. This means that KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with […]

Also posted in Utah's Life Sciences Companies | | Leave a comment

The Point Kick Off

By Denise Bell | Published September 18, 2020

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

Also posted in Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

By Denise Bell | Published September 18, 2020

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Also posted in Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

By admin | Published September 11, 2020

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Also posted in Life Sciences Industry News | | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

By admin | Published September 11, 2020

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Also posted in Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members